Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Feb 23, 2015
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2015-02-19$12.00/sh+12,000$144,000→ 18,386 total
4 · Bellerophon Therapeutics, Inc. · Filed Feb 23, 2015
Common Stock